CDHR5 and colitis: Consistently, shortening of the colon length as indicator for colitis severity was increased in DSS‐treated CDHR5∆/∆ and CDHR5+/∆ mice but not oxazolone‐ or TNBS‐treated mice (Fig 3H–J).